Enanta Pharmaceuticals, Inc. (ENTA)
NMS – Real Time Price. Currency in USD
13.43
-0.09 (-0.67%)
Market open: Aug 12, 2026, 11:05 AM EDT
13.52
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
13.43
-0.09 (-0.67%)
Market open: Aug 12, 2026, 11:05 AM EDT
13.52
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Total debt $186.6M significantly exceeds cash reserves ($34.9M), raising financial stability concerns
Total current assets $178.4M exceed Total current liabilities $46.4M, highlighting excellent liquidity
Debt-to-equity ratio (1.6) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-3.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$7.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.84 | 6.05 | 10 | |
| Quick ratio | 3.84 | 5.63 | 10 | |
| Debt to Equity | 1.60 | 0.30 | 4.0 | |
| Debt to Assets | 0.59 | 1.04 | 4.0 | |
| Interest coverage | -3.57 | -16.91 | 1.0 | |
| Weighted average score | 5.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 86M | 79M | 68M | 65M | 69M |
| Gross Profit | 83M | 77M | 65M | 61M | 64M |
| Operating Income | -124M | -137M | -122M | -85M | -60M |
| Net Income | -122M | -134M | -116M | -82M | -62M |
| EBITDA | -121M | -135M | -119M | -81M | -55M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -8.47 | 40.06 | 5.5 |
| Next quarter | 9.99 | 25.9 | 8.0 |
| Current year | 3.05 | 40.18 | 7.0 |
| Next year | -2.32 | 9.84 | 3.5 |
| Weighted average score | 6.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -7.81 | -9.65 | -7.13 | 39.44 | 3.3 |
| Y/Y | 14.96 | 42.19 | 57.55 | 55.25 | 9.5 |
| 3y average | -8.68 | 10.94 | 12.03 | 17.15 | 6.0 |
| 5y average | -11.6 | -27.93 | -26.23 | -265 | 1.0 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |